N-((5-nitrofuran-2-yl)methylene)aniline | 156-44-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃
• 英文名称: N-((5-nitrofuran-2-yl)methylene)aniline
• 英文别名: N-(5-Nitrofurfurylidene)aniline；1-(5-nitrofuran-2-yl)-N-phenylmethanimine
• CAS: 156-44-5
• 化学式: C₁₁H₈N₂O₃
• mdl: MFCD00137027
• 分子量: 216.196
• InChiKey: OQWZYCADSKTIOH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  71.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-((5-nitrofuran-2-yl)methylene)aniline 在 sodium tetrahydroborate 作用下， 以 二氯甲烷 为溶剂， 以79%的产率得到N-((5-nitrofuran-2-yl)methyl)aniline
  参考文献：
  名称：

  A Class of 5-Nitro-2-furancarboxylamides with Potent Trypanocidal Activity against Trypanosoma brucei in Vitro

  摘要：

  Recently, the World Health Organization approved the nifurtimox-eflornithine combination therapy for the treatment of human African trypanosomiasis, renewing interest in nitroheterocycle therapies for this and associated diseases. In this study, we have synthesized a series of novel 5-nitro-2-furancarboxylamides that show potent trypanocidal activity, similar to 1000-fold more potent than nifurtimox against in vitro Trypanosoma brucei with very low cytotoxicity against human He La cells. More importantly, the most potent analogue showed very limited cross-resistance to nifurtimox-resistant cells and vice versa. This implies that our novel, relatively easy to synthesize and therefore cheap, 5-nitro-2-furancarboxylamides are targeting a different, but still essential, biochemical process to those targeted by nifurtimox or its metabolites in the parasites. The significant increase in potency (smaller dose probably required) has the potential for greatly reducing unwanted side effects and also reducing the likelihood of drug resistance. Collectively, these findings have important implications for the future therapeutic treatment of African sleeping sickness.

  DOI：

  10.1021/jm301215e
• 作为产物：
  描述：

  5-硝基糠醛 、 苯胺 以 二氯甲烷 为溶剂， 以89%的产率得到N-((5-nitrofuran-2-yl)methylene)aniline
  参考文献：
  名称：

  A Class of 5-Nitro-2-furancarboxylamides with Potent Trypanocidal Activity against Trypanosoma brucei in Vitro

  摘要：

  Recently, the World Health Organization approved the nifurtimox-eflornithine combination therapy for the treatment of human African trypanosomiasis, renewing interest in nitroheterocycle therapies for this and associated diseases. In this study, we have synthesized a series of novel 5-nitro-2-furancarboxylamides that show potent trypanocidal activity, similar to 1000-fold more potent than nifurtimox against in vitro Trypanosoma brucei with very low cytotoxicity against human He La cells. More importantly, the most potent analogue showed very limited cross-resistance to nifurtimox-resistant cells and vice versa. This implies that our novel, relatively easy to synthesize and therefore cheap, 5-nitro-2-furancarboxylamides are targeting a different, but still essential, biochemical process to those targeted by nifurtimox or its metabolites in the parasites. The significant increase in potency (smaller dose probably required) has the potential for greatly reducing unwanted side effects and also reducing the likelihood of drug resistance. Collectively, these findings have important implications for the future therapeutic treatment of African sleeping sickness.

  DOI：

  10.1021/jm301215e

文献信息

• 5-Amido- and 5-Amino-Substituted Epoxyisoindolo[2,1-<i>a</i>]tetrahydroquinolines and 10-Carboxylic Acids: Their Synthesis and Reactivity
  作者：Vladimir P. Zaytsev、Fedor I. Zubkov、Flavien A. A. Toze、Daria N. Orlova、Maria N. Eliseeva、Dmitry G. Grudinin、Eugeniya V. Nikitina、Alexey V. Varlamov

  DOI：10.1002/jhet.1024

  日期：2013.2

  was shown that the initial N-acylation of the tetrahydroquinolines was followed by a spontaneous [4+2]-cycloaddition of an N-acryloyl substituent to the furan ring. It was established that the intramolecular Diels–Alder reaction of furans is reversible, occurs stereoselectively as exo-addition, and led to target epoxyisoindolo[2,1-a]tetrahydroquinolines with moderate yields. Oxidation and aromatization

  研究了4-R-取代的2-呋喃基-1,2,3,4-四氢喹啉（通过Povarov反应合成）与许多烯烃之间的相互作用。马来酸，二溴马来酸，二氯马来酸和柠康酸酐，以及丙烯酰，甲基丙烯酰，巴豆酰和肉桂酰氯被用作烯烃组分。结果表明，在最初的四氢喹啉的N-酰化反应之后，N-丙烯酰基取代基自发地[4 + 2] -环加成到呋喃环上。它建立在分子内 Diels-Alder反应呋喃的是可逆的，可立体选择性地发生是由于外切-addition，并导致目标epoxyisoindolo [2,1-一个]四氢喹啉，产率中等。进行合成产物的氧化和芳构化。
• A Class of 5-Nitro-2-furancarboxylamides with Potent Trypanocidal Activity against <i>Trypanosoma brucei</i> in Vitro
  作者：Linna Zhou、Gavin Stewart、Emeline Rideau、Nicholas J. Westwood、Terry K. Smith

  DOI：10.1021/jm301215e

  日期：2013.2.14

  Recently, the World Health Organization approved the nifurtimox-eflornithine combination therapy for the treatment of human African trypanosomiasis, renewing interest in nitroheterocycle therapies for this and associated diseases. In this study, we have synthesized a series of novel 5-nitro-2-furancarboxylamides that show potent trypanocidal activity, similar to 1000-fold more potent than nifurtimox against in vitro Trypanosoma brucei with very low cytotoxicity against human He La cells. More importantly, the most potent analogue showed very limited cross-resistance to nifurtimox-resistant cells and vice versa. This implies that our novel, relatively easy to synthesize and therefore cheap, 5-nitro-2-furancarboxylamides are targeting a different, but still essential, biochemical process to those targeted by nifurtimox or its metabolites in the parasites. The significant increase in potency (smaller dose probably required) has the potential for greatly reducing unwanted side effects and also reducing the likelihood of drug resistance. Collectively, these findings have important implications for the future therapeutic treatment of African sleeping sickness.